THIS common condition may speed up Alzheimer's disease: Experts recommend a simple blood test to determine it
A recent study presented at the European Academy of Neurology Congress 2025 reveals that a blood test could predict rapid cognitive decline in early Alzheimer's patients. Researchers at the University of Brescia found insulin resistance, measured by the TyG index, significantly accelerates the disease's progression.
Alzheimer's disease, which is the most common type of dementia, is on the rise. About 57 million people had dementia worldwide in 2021, and the numbers are escalating. This progressive neurodegenerative disorder affects the quality of life, even impacting daily activities, and hence, early diagnosis is crucial.
Researchers have now found that a simple blood test may soon help doctors predict which patients with early Alzheimer's disease are most at risk of rapid cognitive decline. They also found that a common condition related to metabolic disorders could dramatically accelerate the disease.
The research was led by neurologists at the University of Brescia in Italy and was presented at the European Academy of Neurology (EAN) Congress 2025.
Common condition linked to accelerated Alzheimer's disease
The common condition in question is
insulin resistance
. The researchers looked at the records of 315 non-diabetic patients with cognitive deficits, including 200 with biologically confirmed Alzheimer's disease. All participants underwent a TyG index assessment and were followed clinically over three years.
The researchers found that the patients in the highest third of the TyG index within the Mild Cognitive Impairment-AD subgroup declined significantly faster than those with lower readings, losing more than 2.5 points per year on the widely used Mini-Mental State Examination.
The ratio for rapid progression was 4.08 (95% CI 1.06–15.73), which is a fourfold increase in risk.
'Once mild cognitive impairment is diagnosed, families always ask how fast it will progress. Our data show that a simple metabolic marker available in every hospital laboratory can help identify more vulnerable subjects who may be suitable candidates for targeted therapy or specific intervention strategies,' lead investigator Dr Bianca Gumina said in a statement.
Impact of
insulin resistance
on Alzheimer's disease
Though previous research has shown the association between insulin resistance and
Alzheimer's disease
, its role in how quickly the condition progresses has not been much explored. This recent study looked into insulin resistance's impact during the prodromal mild cognitive impairment (MCI) stage, when patients follow highly variable trajectories.
What is insulin resistance
Insulin resistance is a condition where the body's cells do not respond properly to insulin.
Insulin is a hormone produced by the pancreas that helps glucose (sugar) enter cells for energy. To compensate, the pancreas produces more insulin, but over time, this can lead to elevated blood sugar levels (hyperglycemia), increasing the risk of type 2 diabetes and other serious health conditions.
The study
The researchers used the TyG index, a simple and affordable way to measure insulin resistance, to see if metabolic problems could help predict how quickly cognitive decline happens after diagnosis.
'We were surprised to see the effect only in the Alzheimer's spectrum and not in other neurodegenerative diseases. It suggests a disease-specific vulnerability to metabolic stress during the prodromal window, when interventions may still change the trajectory', Dr Gumina added.
Salman Khan Drops Health Bombshell on National TV
The researchers at the University of Brescia, led by Professor Padovani and Professor Pilotto, found that high TyG was also associated with blood–brain barrier disruption and cardiovascular risk factors. However, it showed no interaction with the APOE ε4 genotype, and hinted that metabolic and genetic risks may act through distinct pathways.
'If targeting metabolism can delay progression, we will have a readily modifiable target that works alongside emerging disease-modifying drugs', Dr Gumina concluded.
One step to a healthier you—join Times Health+ Yoga and feel the change
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Top neurosurgeon shares tips to boost memory and improve focus naturally
Dr. Arun L. Naik highlights the importance of acetylcholine for memory and focus. He suggests boosting it naturally through adequate sleep, mental stimulation, and mindfulness practices. Dietary changes, including consuming eggs, nuts, fatty fish, and leafy greens, can also help maintain healthy acetylcholine levels, enhancing cognitive performance and mental clarity. Keeping the brain in the best shape is crucial for overall health and wellness. In today's time, where many are overwhelmed with work and personal responsibilities, being forgetful and losing focus has become increasingly common. Dr. Arun L. Naik, a leading neurosurgeon trained at All India Institute of Medical Sciences (AIIMS), New Delhi, has now shared some science-backed tips to stay sharp and focused. The neurosurgeon says that the key to sharper memory and improved focus lies in one powerful neurotransmitter, acetylcholine. What is acetylcholine Acetylcholine is a neurotransmitter that acts as a communication bridge between neurons. It acts as a chemical messenger that transmits signals between nerve cells and from nerves to muscles. From voluntary muscle movement to complex brain functions such as memory and attention, this neurotransmitter influences nearly every part of the nervous system. Low acetylcholine levels can lead to forgetfulness, difficulty concentrating, and even muscle weakness. Conditions like Alzheimer's disease are linked to acetylcholine deficits. 'As we age, acetylcholine levels can decline, particularly in neurodegenerative conditions like Alzheimer's disease, where the cholinergic system is one of the first to deteriorate. This has led to the use of acetylcholinesterase inhibitors (like donepezil) in treatment, aimed at increasing available acetylcholine in the brain,' the surgeon wrote in a post shared on Instagram. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trending in in 2025: Local network access control [Click Here] Esseps Learn More Undo The key is to boost acetylcholine to enhance cognitive performance and mental clarity. The neurosurgeon has shared some tips on how simple lifestyle changes and dietary choices can help you maintain healthy levels without medication. Let's take a look. How to naturally boost acetylcholine Certain lifestyle changes can help boost acetylcholine. Dr. Naik has suggested making the following changes. Adequate sleep: It is important to prioritize sleep. A good night's rest can help the brain produce acetylcholine. Aim for at least 7–8 hours of quality sleep every night. Mental stimulation: To keep the brain sharp, it is important to challenge it. Engage the brain with activities like puzzles, chess, or reading, which strengthen neural connections and support acetylcholine activity. Learning a new skill, like playing an instrument, can also help Mindfulness: Managing stress is important to keep the brain healthy, as chronic stress depletes acetylcholine. Practicing mindfulness techniques, such as meditation, yoga, or deep breathing. Such practices can lower stress hormones and protect the brain's neurotransmitter balance. What are acetylcholine-rich foods Diet plays a pivotal role in acetylcholine production. Choline, a nutrient found in certain foods, is the building block for this neurotransmitter. The neurosurgeon has recommended adding these acetylcholine-friendly foods into your diet. Eggs: Egg yolks are great source of choline. A single egg provides about 169 mg of choline. This means eating just 2 eggs per day covers 61% of the DV. Nuts and seeds: Eating almonds and flaxseeds can help. Have a small handful of these nuts regularly Fatty fish: Good news for pescatarians. Salmon and other fatty fish are good for the brain. These fish provide omega-3 fatty acids, which enhance acetylcholine function and reduce brain inflammation. Aim for two servings per week. Leafy greens: Eat your greens. Spinach and kale are loaded with nutrients that support the production of the neurotransmitter. These greens also provide antioxidants that protect brain cells. One step to a healthier you—join Times Health+ Yoga and feel the change
Hans India
3 hours ago
- Hans India
A busier social life may signal Alzheimer's risk, says study
New Delhi: While social isolation has long been known a risk factor for Alzheimer's disease, a new study showed that being more sociable can be an early sign of the neurodegenerative disease. The study examined the social habits and genetic data of half a million people whose average age was 56. Researchers from the University of California San Francisco and Boston University found that Alzheimer's may make people more sociable rather than less - at least in the early stages. The study shows that at its earliest stage Alzheimer's doesn't make people less socially engaged. 'Their social lives may even expand,' said co-senior author Ashwin Kotwal, from USCF. 'We don't know for sure if they are engaging more with others, or if those around them are noticing subtle changes and giving them more support,' he added. The data from UK Biobank showed that people with a higher genetic risk for Alzheimer's reported less isolation, participation in a wider range of social activities and happier family relationships. No differences were found between higher-risk and lower-risk individuals in measuring loneliness, friendship quality and emotional support. Social connectedness is believed to delay or reduce the risk of Alzheimer's by promoting cognitive reserve, the brain's ability to maintain normal function despite aging or dementia. The research showed that other non-genetic factors influencing Alzheimer's are physical inactivity, uncontrolled diabetes and high blood pressure, poor sleep, depression, current smoking and certain medications. Experts believe that 30 per cent of Alzheimer's may be attributed to these modifiable risks. Another research earlier this month found that mood disorders like depression, bipolar disorder, or mania after the age of 40 may not be just mental health conditions but can precede motor or cognitive symptoms in various neurodegenerative diseases. Growing evidence suggests these late-life mood disorders (LLMDs) could be early warning signs of neurodegenerative diseases like dementia, even when they appear years before memory loss or other cognitive symptoms become apparent, said researchers from the National Institutes for Quantum Science and Technology (QST), Japan. The study, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association explored the presence of abnormal tau protein - a hallmark of several neurodegenerative diseases - in the brains of 52 participants with LLMDs and 47 healthy controls.
New Indian Express
5 hours ago
- New Indian Express
Advanced treatment for Parkinson's offers better quality of life
When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle weakness, assuming that could be a sign of aging. A retired electrical engineer from Bengaluru, he experienced other symptoms after a few months and the tremors worsened. A few tests later, Nair was diagnosed with Parkinson's disease (PD), a progressive neurological disorder that affects movement apart from cognitive and emotional function. Though initially he managed it with medication, the relief was temporary. However, everything changed for the better early this year, after he underwent magnetic resonance-guided focused ultrasound (MRgFUS), a cutting edge procedure. Within days of the non-invasive treatment, the tremors that had dominated his life for years were nearly gone. Nair's case is one of many that demonstrate how advanced procedures are offering renewed hope to millions of Parkinson's patients. Despite the challenges, evolving technologies like focused ultrasound and deep brain stimulation are transforming management strategies and improving quality of life. Once mostly associated with older adults, PD is now alarmingly affecting younger populations in India, which now reports between 15 and 43 PD cases per one lakh people. Data from the National Institute of Mental Health and Neurosciences (NIMHANS) reveals that nearly 40-45% of Indian patients aged between 22-49 years experience the symptoms, which is nearly 10 years earlier than the global average. A recent study published in the British Medical Journal projects that the global Parkinson's population will reach 25.2 million by 2050, up by over 112% from 2021. South Asia, particularly India, is expected to account for nearly 6.8 million of these cases. The prevalence has been estimated at 267 cases per one lakh people worldwide. Invisible onset PD is the world's second most prevalent neurodegenerative disorder after Alzheimer's. The World Health Organization warns that neurodegenerative diseases, including Parkinson's and Alzheimer's, could surpass cancer as the second leading cause of death globally by 2040. The disease results from the gradual loss of dopamine-producing neurons in the brain. Dopamine is a chemical messenger essential for smooth and coordinated muscle movements. When dopamine levels drop, motor functions become impaired, leading to a range of uncontrollable symptoms. Parkinson's typically strikes people over 60, though younger cases (below 50) are also reported. Men are more likely to develop the condition than women. Some key symptoms of PD include tremors, especially in hands, arms, or legs, bradykinesia (slowness of movement), muscle rigidity, and shuffling gait. The disease is characterised primarily by motor symptoms like TRAP - tremors, rigidity, akinesia, and postural instability (difficulty to maintain balance). Non-motor symptoms such as depression and anxiety, sleep disturbances, cognitive impairment, constipation, and loss of smell (anosmia) are also seen in some patients. People ideally should watch out for are persistent hand tremors, stiffness or reduced arm swing on one side, slowness in daily activities, difficulty with balance or small handwriting, and soft or slurred speech, said Dr Sowmya M, senior consultant of Neurology at Aster RV Hospital, Bengaluru. 'The earliest signs are often so subtle that they go unnoticed or are mistaken for signs of aging or stress. Tremors are the hallmark symptom, typically starting on one side of the body, mostly in a hand or finger while at rest. Non-motor symptoms can appear years before motor symptoms begin. In such cases, people should always consult neurologists as symptoms like anxiety, loss of sense of smell, sleep disturbances, and even subtle cognitive decline are not always linked to Parkinson's by non-specialist physicians and it delays the diagnosis,' Dr Sowmya said. Clinical diagnosis Diagnosing Parkinson's is largely clinical as no blood test or scan can confirm it with certainty. A neurologist typically evaluates a combination of symptoms, medical history, and physical examinations. Imaging tools like MRI or CT scans are used to rule out other conditions, while a specialised nuclear imaging scan, known as DaTscan, can visualise dopamine activity in the brain. 'Diagnosis of Parkinson's disease is primarily based on signs and symptoms, typically motor-related, identified through neurological examination. Medical imaging techniques like positron emission tomography can support the diagnosis,' Dr Lulup Kumar Sahoo, professor in the Neuro Medicine department of IMS and SUM Hospital, Bhubaneswar said. Treatment begins with medications to increase dopamine levels. Patients generally respond well to dopamine supplementation, commonly known as Syndopa. Though many patients benefit from Syndopa, its effects tend to last for only a short period. Levodopa, often combined with Carbidopa, is also a commonly used drug. It helps replenish dopamine and improves muscle control, though its long-term use can lead to side effects such as dyskinesia. New hope Two major breakthroughs in Parkinson's treatment have emerged in recent years - magnetic resonance-guided focused ultrasound (MRgFUS) and deep brain stimulation (DBS). Focused ultrasound is a non-invasive technique that uses sound waves, guided by MRI, to target and destroy tiny areas of brain tissue responsible for tremors, without impacting surrounding healthy tissues. It does not require anaesthesia, surgery, or recovery time. 'A great alternative to traditional brain surgery, focused ultrasound can be beneficial for patients who haven't responded well to medication or prefer non-invasive procedures. Patients come in shaking and walk out with steady hands after the procedure. The treatment requires no surgical incisions or implants, and the mild transient numbness is resolved within days,' said Dr Sunil Patra, senior neurosurgeon at Manipal Hospitals, Bhubaneswar. Dr Sahoo said MRgFUS uses over 1,000 beams of focused ultrasound energy directed at a precise point in the brain, typically the thalamus, which is involved in motor control. Guided in real time by high-resolution MRI imaging, the treatment raises the temperature of the targeted tissue to a point where it is thermally ablated, disrupting the abnormal brain circuits causing tremors. 'The entire process is performed without scalpels, anaesthesia, or hospitalisation. Patients remain awake and responsive, allowing physicians to evaluate the effects in real time. Most patients experience immediate and significant reduction in tremor, immediately after the procedure. It, however, costs around `25 lakh, almost double the cost of DBS,' he added. DBS, on the other hand, involves implanting electrodes into specific brain regions such as the subthalamic nucleus or globus pallidus, guided by MRI. These electrodes deliver controlled electrical pulses that modulate abnormal brain activity. DBS can significantly reduce tremors, stiffness, and medication dependence. 'In DBS surgery or brain pacemaker surgery, small burrholes (keyhole) are made in the skull and electrodes are placed deep inside the brain under stereotactic guidance. These electrodes will be connected to a battery placed in the subcutaneous pouch in the upper chest. Based on the patient's symptomatic profile, the electrodes can be activated by switching on the battery with specified current. The electrodes will stimulate the desired neurons and give symptomatic relief,' Dr T P Jeyaselva Senthilkumar, senior consultant neurosurgeon, SRM Global Hospitals, Chennai. 'It is a one-day procedure and requires the patient to stay at the hospital for five days for observation and wound healing. The programming of the impulse generator battery will begin after two weeks, once the patient is stable. It is another one-day procedure,' added Dr Asha Kishore, director of the Parkinson's and Movement Disorders Centre at Aster Kerala Cluster. Senthilkumar added that to be eligible for DBS, the patient should have been responsive to oral medications. The total cost can range from Rs 15.5 lakh to Rs 20 lakh, based on model of implant used.
